(redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
Two case studies exemplify many of the issues that will be discussed.doi:10.1016/S1062-0303(98)90010-3Marjorie J. PageElsevier BVJournal of Vascular NursingPage MJ. Factor V Leiden mutation: a nursing perspective. J Vasc Nurs. 1998; 16 :73–77....
Factor V Leiden 第五凝血因子；莱登第五因子 第五凝血因子 检验第五凝血因子(Factor V leiden)上的G1691A突变：造成容易产生血栓的体质(血栓病, thrombophilia)。北美洲有 5% 的人遗传有莱登第五因子 ( Factor V Leiden )﹐影响凝血功能。 年长﹑肥胖﹑抽烟﹐与及曾经出现过静脉栓塞症状的人士﹐再次...
Factor V Leiden mutation, prothrombin gene mutation, …:凝血因子V莱顿突变,凝血酶原基因突变,…V,凝血,突变,gene,因子V莱顿,凝血因子V,突变,Gene,反馈意见 文档格式: .pdf 文档大小: 57.94K 文档页数: 5页 顶/踩数: 0/0 收藏人数: 0 评论次数: ...
Factor V Leiden mutation (Arg506Gln) increases the likelihood of venous thrombosis; it may also have a positive effect through facilitation of embryo implantation. This may manifest itself as a reduced time to pregnancy (increased fecundity) and fewer miscarriages in the first trimester.From March ...
Factor V (Leiden), Mutation Analysis CPT Code:81241 Order Code:1089 ABN Requirement:No Specimen: Whole Blood Volume: 5.0 mL Minimum Volume: 3.0 mL Container:EDTA (lavender-top) (preferred) EDTA (royal blue-top) Sodium heparin (green-top) ACD solution A (yellow-top) ACD solution B (...
Aim. Lebanon exhibits one of the highest prevalences of factor V-Leiden (FVL) in the world (14.4%). The aim of this study is to evaluate the incidence of FVL mutation among Lebanese patients with lower extremity venous thrombosis. Material and Methods. From January 2003 to January 2011, 28...
factor-V Leidenfactor-V Leiden A common mutation of coagulation factor-V gene, which is found in 3 to 8% of Caucasians, and results in resistance to activated C protein and an increased risk in deep-vein and other thromboses. Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights...
遗传阻断导读:Factor V Leiden易栓症是一种儿科疾病。佳学基因对Factor V Leiden易栓症的发生进行了基因解码,并将之收入《人的基因序列变化与人体疾病表征》中,便于医生选择和使用,进行Factor V Leiden易栓症遗传阻断,也便于患者更好地进行治疗和健康管理。
Factor V Leiden mutation is a common genetic risk factor for venous thrombosis. It has been documented in up to 65% of patients with unexplained venous thromboembolism. This genetic mutation is now known to be the most common inherited cause of activated protein C (APC) resistance. Recently, ...